Bio-Rad Laboratories (15) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Amendment No. 2 dated as of April 15, 2022 to Credit Agreement dated as of April 15, 2019, by and among Bio-Rad Laboratories, Inc., the lenders referred to therein, and JPMorgan... (Filed With SEC on April 20, 2022)
Underwriting Agreement, dated as of February 23, by and among Bio-Rad Laboratories, Inc. and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC... (Filed With SEC on March 2, 2022)
Indenture, dated as of March 2, 2022, by and between Bio-Rad Laboratories, Inc. and Wilmington Trust, National Association (Filed With SEC on March 2, 2022)
Form of Global Security for the 3.300% Senior Notes due 2027 (Filed With SEC on March 2, 2022)
Description of Bio-Rad Laboratories, Inc. Class A and Class B Common Stock (Filed With SEC on March 2, 2020)
First Supplemental Indenture, dated as of March 2, 2022, by and between Bio-Rad Laboratories, Inc. and Wilmington Trust, National Association (Filed With SEC on March 2, 2022)
Form of Global Security for the 3.700% Senior Notes due 2032 (Filed With SEC on March 2, 2022)
Amendment No. 1 dated as of November 15, 2021 to Credit Agreement dated as of April 15, 2019, by and among Bio-Rad Laboratories, Inc., the lenders referred to therein, and... (Filed With SEC on November 18, 2021)
Credit Agreement, dated as of April 15, 2019, by and among Bio-Rad Laboratories, Inc., the lenders referred to therein, JPMorgan Chase Bank, N.A., as administrative agent, Bank of... (Filed With SEC on April 16, 2019)